![Monte Rosa Therapeutics, Inc. logo](/logos/GLUE.webp)
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
Overview | Financials
Company Name | Monte Rosa Therapeutics, Inc. |
Symbol | GLUE |
Currency | USD |
Price | 5.69 |
Market Cap | 349,211,232 |
Dividend Yield | 0% |
52-week-range | 2.44 - 8.84 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Markus Warmuth M.D. |
Website | https://www.monterosatx.com |
An error occurred while fetching data.
About Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD